Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

ViOptix, Inc. — Predicate Candidate Screening

9 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

104 daysmedian FDA review time
339 days90th percentile
9clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K250519Lap.Ox™ Laparoscopic Tissue OximeterViOptix, Inc.2025-06-261250
K233488Intra.Ox™ 2.0 Handheld Tissue OximeterVioptix, Inc.2024-02-281240
K221010Intra.Ox 2.0 Handheld Tissue OximeterVioptix, Inc.2022-05-03280
K191676Intra.Ox 2.0 Handheld Tissue OximeterVioptix, Inc.2019-09-16840
K163472Intra.Ox Handheld Tissue OximeterVioptix, Inc.2017-11-163390
K133983INTRA. OX HANDHELD TISSUE OXIMETERVioptix, Inc.2014-09-122590
K141234ODISSEY TISSUE OXIMETERVioptix, Inc.2014-07-01490
K090679VESSELINK MICROVASCULAR ANASTOMOTIC COUPLER SYSTEMVioptix, Inc.2009-04-17320
K042657VIOPTIX ODISSEY TISSUE OXIMETER TISSUE OXIMETER, MODEL OXY-2Vioptix, Inc.2005-01-101040

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda